相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Accuracy of Biomarker Testing for Neuropathologically Defined Alzheimer Disease in Older Adults With Dementia A Systematic Review
Howard A. Fink et al.
ANNALS OF INTERNAL MEDICINE (2020)
Effectiveness of psychological treatments for depressive symptoms among people living with HIV/AIDS in low- and middle-income countries: A systematic review and meta-analysis
Biksegn Asrat et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Neurocognitive Effects of Antiretroviral Initiation Among People Living With HIV in Rural Uganda
Alyssa Vecchio et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2020)
Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease
Andrea Vergallo et al.
ALZHEIMERS & DEMENTIA (2019)
Heterogeneity in neurocognitive change trajectories among people with HIV starting antiretroviral therapy in Rakai, Uganda
Leah H. Rubin et al.
JOURNAL OF NEUROVIROLOGY (2019)
HIV, Depression, and Cognitive Impairment in the Era of Effective Antiretroviral Therapy
Leah H. Rubin et al.
CURRENT HIV/AIDS REPORTS (2019)
Prevalence of depressive symptoms and associated factors among adolescents living with HIV/AIDS in South Western Uganda
Elizabeth Kemigisha et al.
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV (2019)
Depressive Symptoms Before and After Antiretroviral Therapy Initiation Among Older-Aged Individuals in Rural Uganda
Jennifer Manne-Goehler et al.
AIDS AND BEHAVIOR (2019)
Efavirenz is related to neuropsychiatric symptoms among adults, but not among adolescents living with human immunodeficiency virus in Kilimanjaro, Tanzania
Marion Sumari-de Boer et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2018)
Depression and Suicidal Ideation Among HIV-Infected Adults Receiving Efavirenz Versus Nevirapine in Uganda A Prospective Cohort Study
Jonathan L. Chang et al.
ANNALS OF INTERNAL MEDICINE (2018)
Prevalence, Comorbidity, and Correlates of Psychiatric and Substance Use Disorders and Associations with HIV Risk Behaviors in a Multisite Cohort of Women Living with HIV
Judith A. Cook et al.
AIDS AND BEHAVIOR (2018)
Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda
Mahsa Abassi et al.
JOURNAL OF NEUROVIROLOGY (2017)
Prevalence and factors associated with depression in people living with HIV in subSaharan Africa: A systematic review and meta analysis
Charlotte Bernard et al.
PLOS ONE (2017)
Depression and Anxiety are Common in Acute HIV Infection and Associate with Plasma Immune Activation
Joanna Hellmuth et al.
AIDS AND BEHAVIOR (2017)
Antiretroviral Therapy Initiation and Changes in Self-Reported Depression
Ellen F. Eaton et al.
CLINICAL INFECTIOUS DISEASES (2017)
Depression and Engagement in Care Among Newly Diagnosed HIV-Infected Adults in Johannesburg, South Africa
R. Cholera et al.
AIDS AND BEHAVIOR (2017)
Latent Profile Analysis: Understanding Family Firm Profiles
Laura Stanley et al.
FAMILY BUSINESS REVIEW (2017)
Depression at antiretroviral therapy initiation and clinical outcomes among a cohort of Tanzanian women living with HIV
Christopher R. Sudfeld et al.
AIDS (2017)
Validation of screening tools for depression and anxiety disorders in a primary care population with high HIV prevalence in Zimbabwe
Dixon Chibanda et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
Identifying Neurocognitive Decline at 36 Months among HIV-Positive Participants in the CHARTER Cohort Using Group-Based Trajectory Analysis
Marie-Josee Brouillette et al.
PLOS ONE (2016)
Factors associated with initiation of antiretroviral therapy in the advanced stages of HIV infection in six Ethiopian HIV clinics, 2012 to 2013
Denis Nash et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2016)
Determinants of common mental disorder, alcohol use disorder and cognitive morbidity among people coming for HIV testing in Goa, India
Rosie Mayston et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2015)
Excess Burden of Depression among HIV-Infected Persons Receiving Medical Care in the United States: Data from the Medical Monitoring Project and the Behavioral Risk Factor Surveillance System
Ann N. Do et al.
PLOS ONE (2014)
Longitudinal Characterization of Depression and Mood States Beginning in Primary HIV Infection
Jessica A. Gold et al.
AIDS AND BEHAVIOR (2014)
PREVALENCE AND RISK FACTORS OF DEPRESSION IN ETHIOPIA: A REVIEW
Tesera Bitew
ETHIOPIAN JOURNAL OF HEALTH SCIENCES (2014)
Depressive symptoms in HIV-infected patients treated with highly active antiretroviral therapy
Marysabel Pinto Telis Silveira et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2012)
Depression, Alcohol Use and Adherence to Antiretroviral Therapy in Sub-Saharan Africa: A Systematic Review
Etheldreda Nakimuli-Mpungu et al.
AIDS AND BEHAVIOR (2012)
Utilizing reliable and clinically significant change criteria to assess for the development of depression during smoking cessation treatment: The importance of tracking idiographic change
Andrew M. Busch et al.
ADDICTIVE BEHAVIORS (2011)
Race/Ethnicity and the Factor Structure of the Center for Epidemiologic Studies Depression Scale: A Meta-Analysis
Giyeon Kim et al.
CULTURAL DIVERSITY & ETHNIC MINORITY PSYCHOLOGY (2011)
Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda
Noeline Nakasujja et al.
BMC PSYCHIATRY (2010)
Validity/Reliability of PHQ-9 and PHQ-2 Depression Scales Among Adults Living with HIV/AIDS in Western Kenya
Patrick O. Monahan et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2009)
Validity of cognitive complaints in substance-abusing patients and non-clinical controls: The Patient's Assessment of Own Functioning Inventory (PAOFI)
Randall Richardson-Vejlgaard et al.
PSYCHIATRY RESEARCH (2009)
From inflammation to sickness and depression: when the immune system subjugates the brain
Robert Dantzer et al.
NATURE REVIEWS NEUROSCIENCE (2008)
The role of IL-12 and TGF-β1 in the pathophysiology of major depressive disorder
Kyung-Min Lee et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2006)
Prediction of neuropsychiatric adverse events associated with long-term efavirenz therapy, using plasma drug level monitoring
F Gutiérrez et al.
CLINICAL INFECTIOUS DISEASES (2005)
Psychiatric issues in the management of patients with HIV infection
GJ Treisman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States
EG Bing et al.
ARCHIVES OF GENERAL PSYCHIATRY (2001)
Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients
C Marzolini et al.
AIDS (2001)
分享论文
